Core Viewpoint - The company’s subsidiary, Jiangsu Saifusi Biotechnology Co., Ltd., successfully passed the Qualified Person (QP) audit, achieving compliance with EU GMP standards, which is crucial for its international market strategy [1] Group 1: Audit and Compliance - The QP audit was conducted over three days by a senior QP, who reviewed the quality management system and production capabilities of Saifusi [1] - The audit team recognized Saifusi's high standards in quality management, advanced facilities, and professional technical team, confirming compliance with EU GMP requirements [1] - A compliance statement issued by the QP serves as a strong proof of the company's adherence to international GMP standards, essential for entering the EU market [1] Group 2: Strategic Importance - Passing the QP audit is a significant milestone for the company's product export strategy and global expansion plans [1] - This achievement lays a solid foundation for the company's future innovative products to enter international markets [1]
荃信生物-B：荃信生物产业化基地成功通过欧盟QP审计